Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Invuity Inc    IVTY

INVUITY INC (IVTY)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/12/2018 02/13/2018 02/14/2018 02/15/2018 02/16/2018 Date
4.5(c) 3.95(c) 3.85(c) 4.1(c) 4.15(c) Last
277 451 479 849 457 830 260 387 157 790 Volume
+12.50% -12.22% -2.53% +6.49% +1.22% Change
More quotes
Financials ($)
Sales 2018 47,0 M
EBIT 2018 -29,3 M
Net income 2018 -32,4 M
Debt 2018 -
Yield 2018 -
Sales 2019 56,4 M
EBIT 2019 -23,3 M
Net income 2019 -26,1 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 1,51x
Capi. / Sales2019 1,26x
Capitalization 71,1 M
More Financials
Company
Invuity, Inc. is a medical technology company, which engages in the development and marketing of surgical and medical devices.Its products include retractors, handhelds, and drop-ins under the Photonics and PhotonBlade brands.The company was founded by Kenneth B. Trauner and Alex Vayser on November... 
More about the company
Surperformance© ratings of Invuity Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on INVUITY INC
02/01Invuity to Present at Leerink Global Healthcare Conference
GL
01/31INVUITY : Announces 2017 Fourth Quarter, Full Year Financial Results and Confere..
AQ
2017INVUITY : Patent Issued for Illuminated Suction Apparatus (USPTO 9833295)
AQ
2017Invuity Appoints Scott Flora to Board of Directors
GL
2017INVUITY,INC. (NASDAQ : IVTY) Files An 8-K Departure of Directors or Certain Offi..
AQ
2017Invuity to Present at Piper Jaffray Healthcare Conference
GL
2017INVUITY, INC. : Change in Directors or Principal Officers, Financial Statements ..
AQ
2017Invuity to Present at Upcoming Investor Conferences
GL
2017INVUITY : reports 3Q loss
AQ
2017INVUITY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
More news
Sector news : Medical Equipment
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
02/15STRAUMANN : margin outlook takes shine off revenue surge
RE
02/15COLOPLAST A/S : ConvaTec beats low full-year expectations, shares rise
RE
02/07ESSILOR INTERNATIONAL : Makes Changes to Board of Directors
DJ
02/06BECTON DICKINSON AND : Revenue Helped by Life-Sciences -- Earnings Review
DJ
More sector news : Medical Equipment
Latest Tweets
02/16William Blair Lowers Invuity Q1 2018 Earnings Estimates to ($0.55) EPS (Previ.. 
02/16Leerink Swann Raises Invuity Q1 2018 Earnings Estimates to ($0.45) EPS (Previ.. 
02/15William Blair Sets Invuity FY2019 Earnings Estimates at ($1.44) EPS.  
02/14Invuity $IVTY Releases Quarterly Earnings Results, Beats Expectations By $0.0.. 
02/14Northland Securities Issues a Buy Rating on Invuity $IVTY  
More tweets
Qtime:90
News from SeekingAlpha
02/13Invuity's (IVTY) CEO Philip Sawyer on Q4 2017 Results - Earnings Call Transcr.. 
02/13Invuity beats by $0.06, misses on revenue 
02/05Letter To Invuity Management 
2017Invuity (IVTY) Presents At 8th Annual Craig-Hallum Alpha Select Conference - .. 
2017Invuity (IVTY) Presents At Stifel 2017 Healthcare Conference - Slideshow 
Chart INVUITY INC
Duration : Period :
Invuity Inc Technical Analysis Chart | IVTY | US46187J2050 | 4-Traders
Technical analysis trends INVUITY INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Average target price 7,40 $
Spread / Average Target 78%
EPS Revisions
Managers
NameTitle
Philip M. Sawyer President, Chief Executive Officer & Director
Gregory T. Lucier Chairman
Douglas W. Heigel Senior Vice President-Operations
James H. Mackaness Chief Financial Officer
Alex Vayser Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
INVUITY INC-37.90%66
ASAHI INTECC CO., LTD.3.67%4 984
MASIMO CORPORATION1.34%4 385
JIANGSU YUYUE MDCL EQPMNT & SPPLY CO LTD--.--%3 292
GETINGE-15.08%3 248
PENUMBRA INC-0.53%3 177